Asia Pacific Bioanalytical Testing Services Market to Grow at 11.2% Through 2031 Reaching $13.35 Billion – ResearchAndMarkets.com

Asia Pacific Bioanalytical Testing Services Market to Grow at 11.2% Through 2031 Reaching $13.35 Billion – ResearchAndMarkets.com




Asia Pacific Bioanalytical Testing Services Market to Grow at 11.2% Through 2031 Reaching $13.35 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

Based on Molecule Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Small Molecules
  • Large Molecules
  • LC-MS Studies
  • Immunoassays
  • Other Large Molecule Tests

Based Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Bioavailability and Bioequivalence Studies
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Absorption, Distribution, Metabolism, Excretion (ADME)
  • Other Applications

By Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Cell-based Assays
  • Bacterial Cell-based Assays
  • Viral Cell-based Assays
  • Virology Testing
  • In Vitro Virology Testing
  • In Vivo Virology Testing
  • Species-Specific Viral PCR Assays
  • Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
  • Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
  • Viral Serology, Immunogenicity, and Neutralizing Antibodies
  • Method Development Optimization and Validation (MDOV)
  • Biomarker Testing
  • Pharmacokinetic Testing
  • Other Test Types

By Workflow Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Sample Preparation
  • Protein Precipitation
  • Liquid-liquid Extraction (LLE)
  • Sample Analysis
  • Hyphenated Technique
  • Chromatographic Technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
  • Other Workflow Processes

By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology
  • Other Therapeutic Areas

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

  • Pharma and Biopharma Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Contract Research Organizations (CROs) 

Selected Key Players:

  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Eurofins Scientific
  • ICON PLC
  • Intertek Group PLC
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Pace Analytical Services LLC.
  • Parexel International Corporation
  • PPD Inc.
  • SGS SA
  • Syneos Health, LLC
  • Toxikon Corporation
  • WuXi Apptech Co., Ltd.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Market by Molecule Type

4 Segmentation of Asia Pacific Market by Application

5 Segmentation of Asia Pacific Market by Test Type

6 Segmentation of Asia Pacific Market by Workflow Process

7 Segmentation of Asia Pacific Market by Therapeutic Area

8 Segmentation of Asia Pacific Market by End User

9 Asia-Pacific Market 2021-2031 by Country

10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/xxq5rt

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900